Restarting Wellbutrin After Less Than One Month Off
You can restart Wellbutrin immediately without any required washout period when the patient has been off the medication for less than one month. 11
Key Principles for Restarting
No mandatory waiting period exists for reinitiating bupropion after a brief discontinuation of less than 4 weeks. The FDA labeling addresses switching to/from MAOIs (requiring 14 days) but specifies no washout when simply restarting the same medication. 11
Resume at the previous therapeutic dose if the patient was tolerating it well before discontinuation, as the FDA guidance for switching between bupropion formulations states to "give the same total daily dose when possible." 11
Clinical Approach to Restarting
If Previously on 300 mg Daily
- Restart directly at 300 mg once daily (for XL formulation) if the patient had achieved stable dosing without adverse effects before stopping. 11
If Uncertain About Tolerance or Prior Adverse Effects
- Begin at 150 mg once daily for 3-4 days, then increase to 300 mg daily to reassess tolerability, particularly if the reason for discontinuation was unclear or involved side effects. 12
Critical Safety Monitoring After Restart
First 1-2 weeks: Systematically assess for suicidal ideation, agitation, irritability, behavioral changes, and emergence of depressive symptoms, as the highest risk period for suicidality occurs in the first 1-2 months of antidepressant treatment. 31
Seizure risk assessment: Verify that no new contraindications have developed during the off-medication period, including new eating disorders (bulimia/anorexia), initiation of medications that lower seizure threshold, or new alcohol/benzodiazepine use patterns that might lead to abrupt discontinuation. 11
Common Pitfalls to Avoid
Do not assume a washout is needed simply because the patient stopped the medication—unlike MAOIs, bupropion can be restarted immediately. 11
Do not exceed maximum dosing (450 mg/day for immediate-release, 400 mg/day for sustained-release) even if the patient had suboptimal response previously, as seizure risk increases dose-dependently. 2
Do not ignore the reason for initial discontinuation: If the patient stopped due to adverse effects (particularly urticaria, angioedema, or dystonia), consider whether rechallenge is appropriate or whether a different formulation might be better tolerated. 45
Monitor adherence closely: Research shows that 28% of patients discontinue antidepressants after the first prescription, and among those who restart, only 29.3% continue for 6 months or more—emphasizing the need for close follow-up and adherence support. 6